Apr 24, 2012 | BioSpace
The Law Firm of Notifies Investors with Losses on Their Investment in ...
The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in NeurogesX, Inc.
NeurogesX Receives Determination Letter From NASDAQ
NeurogesX, Inc. , a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies, today announced that it received a determination letter from the Staff of The NASDAQ Stock Market LLC on April 17, 2012, indicating that it has not regained compliance with NASDAQ Listing Rule ... (more)
NeurogesX, Inc. Engages to Execute Business Development Strategy
SAN MATEO, Calif., April 17, 2012 -- NeurogesX, Inc. , a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies, today announced that it has engaged JSB-Partners, a global life sciences advisor, to assist the Company in executing its business development objectives that ... (more)
NeurogesX, Inc. Provides Update on NGX-1998 Clinical Program
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia SAN MATEO, Calif., April 11, 2012 -- NeurogesX, Inc.